Incyte stock drops 67% 2000
WebGet Incyte Corp (INCY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebLooking back, over the last four weeks, Incyte Corp lost 7.54 percent. Over the last 12 months, its price fell by 3.03 percent. Looking ahead, we forecast Incyte Corp to be priced at 69.71 by the end of this quarter and at 63.25 in one year, according to Trading Economics global macro models projections and analysts expectations. Stock Price 72.20
Incyte stock drops 67% 2000
Did you know?
WebCompany Description: Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. It is focused on developing and selling drugs that inhibit specific enzymes associated with cancer and other diseases. The company's lead program is its JAK (Janus associated kinase) inhibitor program. WebOct 3, 2024 · Based on the latest available data, INCY has gained about 14.86% so far this year. Meanwhile, stocks in the Medical group have lost about 2.46% on average. This …
WebBuy Incyte Corporation Stocks. Updated May 13, 2024. Incyte Corporation is a biotechnology business based in the US. Incyte Corporation shares (INCY) are listed on the NASDAQ and all prices are listed in US Dollars. Incyte Corporation employs 2,094 staff and has a trailing 12-month revenue of around $3.3 billion. WebIncyte (ICY) last ex-dividend date was on ―. Incyte distributed ― per share that represents a ― dividend yield. ... Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener. Dividend Investing. Dividend Calculator Dividend Yield Calculator Dividend Stocks Dividend News Dividend Calendar. ETFs. Top ETFs by AUM SPY ETF ...
WebApr 11, 2024 · 3 brokerages have issued 1-year price objectives for Inogen's stock. Their INGN share price forecasts range from $22.00 to $30.00. On average, they expect the … WebIncyte Corp. Annual cash flow by MarketWatch. View INCY net cash flow, operating cash flow, operating expenses and cash dividends. ... -4.67%. 25.10%. Investing Activities All values USD. Item ...
WebMar 31, 2024 · According to analysts, Incyte's stock has a predicted upside of 10.67% based on their 12-month price targets. What analysts cover Incyte? Incyte has been rated by …
WebFeb 7, 2024 · Incyte , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $926.7 million for the quarter ended December 2024, … sigeberht of east angliaWeb28.46M. -94.95%. Net profit margin. Measures how much net income or profit is generated as a percentage of revenue. 3.07. -95.30%. Earnings per share. Represents the company's profit divided by ... sigec bastiaWebFeb 16, 2024 · Incyte Historical Price Data (INCY) - Investing.com Stock Screener United States Pre-Market World ADRs Stock Brokers Americas Europe Middle East Fed Rate Monitor Tool Incyte Corporation... sigecaps and digfastWebFeb 23, 2000 · NEW YORK (CNNfn) - Bullish on the outlook for the already high-flying genomics segment of the biotech industry, a Wall Street analyst raised his 12-month price … sigecaps screening toolWebIncyte (INCY) Down 9.6% so Far in 2024 on Recent Setbacks. Apr 05 / Zacks.com - Paid Partner Content. Company News for Mar 27, 2024. Mar 27 / Zacks.com - Paid Partner … sigec hocWebMar 31, 2024 · INCYTE CORPORATION : ICY Stock Price US45337C1027 MarketScreener Homepage Equities Germany Börse Stuttgart Incyte Corporation Summary ICY US45337C1027 INCYTE CORPORATION (ICY) Add to my list Report Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Quotes 5-day … sig echo1WebWhat is Incyte's Market Cap? ( NASDAQ: INCY) Incyte 's market cap is $16.41B, as of Mar 21, 2024. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Incyte 's market cap is calculated by multiplying INCY 's current stock price of $73.62 by INCY 's total outstanding shares of 222,965,018. sigecaps screening